Orbitrap Fusion Lumos Tribrid Mass Spectrometer Wins Scientists’ Choice Award for Best New Drug Discovery Product of 2015
OREANDA-NEWS. January 28, 2016. The global community of SelectScience readers and contributors has named the Thermo Scientific Orbitrap Fusion Lumos Tribrid Mass Spectrometer the Best New Drug Discovery Product of 2015. This award recognizes the company with the highest reviews and ratings on SelectScience, an online resource that fulfills the information needs of the global scientific community.
SelectScience announced the winner this week at an awards ceremony at the Annual Conference and Exhibition of the Society for Laboratory Automation and Screening (SLAS) in San Diego. Last year, the SelectScience community awarded the Thermo Scientific Vanquish High-Performance Liquid Chromatography system with Best New Separations Product and named Thermo Fisher Scientific as Company of the Year.
“This Scientists’ Choice Award celebrates the new technologies that made the biggest impact in drug discovery and development research in 2015,” said Arif Butt, CEO and founder of SelectScience. “The awards are unique in this industry as they empower scientists to nominate and vote for their favorite new product, enabling them to have their say in the manufacturers that have truly enabled their work. Congratulations to Thermo Fisher Scientific on this significant achievement.”
“We aim to deliver technology innovations that enable our customers to make impactful scientific discoveries,” said Dan Shine, senior vice president, analytical instruments at Thermo Fisher. “Ten years ago, we introduced the first Orbitrap-based mass spectrometer and this opened up new possibilities in life sciences research. Since then, we have continued to deliver new levels of performance for scientists conducting the most challenging work. We are proud that the scientific community recognizes the pioneering contributions of our newest addition, the Orbitrap Fusion Lumos MS.”
Scientists pushing the limits of quantitation and protein characterization require more expansive and in-depth analytical information. The OrbitrapFusion Lumos Tribrid MS addresses this need for scientists conducting proteomics, biopharma and metabolomics research. The broad advances made in the new-generation Orbitrap Fusion Lumos MS instrument deliver increased sensitivity and an enhanced feature set, allowing scientists to perform more comprehensive sample analyses faster and with better accuracy than our mass spectrometers ever have before.
For more information about the Orbitrap Fusion Lumos system, an essential tool for high-end life science research, please visit www.thermoscientific.com/lumos.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of \\$17 billion and approximately 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.
Комментарии